664. Are Thousands of Medical Cures Hiding in Plain Sight?
This episode of Freakonomics Radio, guest-hosted by economist Steve Levitt, explores the untapped potential of repurposing existing drugs to treat rare and deadly diseases, highlighting both the scientific promise and the broken economic incentives that prevent widespread adoption. The st
Sign up to read the full summary
Free AI-powered recaps of every episode, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.
Guest
David Fajgenbaum
narrative on Freakonomics Radio
Mentions
Books, people, and resources mentioned in this episode.
People
Companies
Products & Tools
Research & Papers
Topics
Listen to This Episode
More from Freakonomics Radio
All You Need Is Nudge (Update)
671. Why Has There Been So Little Progress on Alzheimer’s Disease?
666. This Is How Progress Happens
668. Do Taylor Swift and Bad Bunny Have Blood on Their Hands?
674. How Does a Composer Feel After the World Premiere?
In a Driverless World, Who Loses and Who Wins?
Related episodes
From other shows on similar topics.
#374 - "Doctors Are Legally BANNED From Telling You This" - Pharma Whistleblower | Brigham Buhler
Danny Jones Podcast
Longer Life: What Does Science Say?
On with Kara Swisher
Ozempic for All?
The Daily
D.A. Wallach Explains Why Biotech VC Is So Different
Odd Lots
The French Industrialist Betting on Robotics to Cure Disease (And the Ethical Line He Won’t Cross) | Ep. 316 with Hervé de Malliard President of Maison MGA
Founder's Story
Avoiding, Treating & Curing Cancer With the Immune System | Dr. Alex Marson
Huberman Lab
Get summaries like this every morning.
Free AI-powered recaps of Freakonomics Radio and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.